Microcins reveal natural mechanisms of bacterial manipulation to inform therapeutic development

Abstract

Microcins are an understudied and poorly characterized class of antimicrobial peptides. Despite the existence of only 15 examples, all identified from the Enterobacteriaceae , microcins display diversity in sequence, structure, target cell uptake, cytotoxic mechanism of action and target specificity. Collectively, these features describe some of the unique means nature has contrived for molecules to cross the ‘impermeable’ barrier of the Gram-negative bacterial outer membrane and inflict cytotoxic effects. Microcins appear to be widely dispersed among different species and in different environments, where they function in regulating microbial communities in diverse ways, including through competition. Growing evidence suggests that microcins may be adapted for therapeutic uses such as antimicrobial drugs, microbiome modulators or facilitators of peptide uptake into cells. Advancing our biological, ecological and biochemical understanding of the roles of microcins in bacterial interactions, and learning how to regulate and modify microcin activity, is essential to enable such therapeutic applications.

Document Details

Document Type
Pub Defense Publication
Publication Date
Apr 08, 2022
Source ID
10.1099/mic.0.001175

Entities

People

  • Bryan W Davies
  • J K Parker

Organizations

  • Defense Advanced Research Projects Agency
  • Defense Threat Reduction Agency
  • National Institutes of Health
  • University of Texas at Austin

Tags

Fields of Study

  • Biology

Readers

  • Microbial Pathology
  • Oncology (Cancer Research).
  • Systems Analysis and Design

Technology Areas

  • Biotechnology